TickerFacts.

UFP Technologies Inc (UFPT): Operating Cash Flow

Annual figures by period end, from SEC filings.

$91.91M
Year ended 2025-12-31
$71.58M
Trailing 12 months to 2026-06-30
+73.0%
3-year compound annual growth
+29.7%
5-year compound annual growth
+22.1%
10-year compound annual growth
2015-12-31: $12.52M2016-12-31: $9.31M2017-12-31: $17.47M2018-12-31: $21.32M2019-12-31: $31.23M2020-12-31: $25.04M2021-12-31: $14.29M2022-12-31: $17.74M2023-12-31: $41.33M2024-12-31: $66.59M2025-12-31: $91.91M$91.91M
2015-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$91.91M+38.0%2026-02-27, From 2025-01-01
2024-12-31$66.59M+61.1%2026-02-27, From 2024-01-01
2023-12-31$41.33M+132.9%2026-02-27, From 2023-01-01
2022-12-31$17.74M+24.1%2025-03-03, From 2022-01-01
2021-12-31$14.29M-42.9%2024-02-29, From 2021-01-01
2020-12-31$25.04M-19.8%2023-03-16, From 2020-01-01
2019-12-31$31.23M+46.5%2022-03-14, From 2019-01-01
2018-12-31$21.32M+22.0%2021-03-12, From 2018-01-01
2017-12-31$17.47M+87.7%2020-03-13, From 2017-01-01
2016-12-31$9.31M-25.7%2019-03-15, From 2016-01-01
2015-12-31$12.52Mn/a2018-03-16, From 2015-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
UFP Technologies Inc (UFPT)2025-12-31$91.91M+38.0%
Bioventus Inc. (BVS)2025-12-31$74.67M+92.5%
NovoCure Ltd (NVCR)2025-12-31-$49.03Mn/m
AtriCure, Inc. (ATRC)2025-12-31$57.33M+369.8%
Glaukos Corp (GKOS)2025-12-31-$14.79Mn/m
iRhythm Holdings, Inc. (IRTC)2025-12-31$80.86Mn/m
Alphatec Holdings, Inc. (ATEC)2025-12-31$45.23Mn/m
Orthofix Medical Inc. (OFIX)2025-12-31$33.35M+29.3%
Artivion, Inc. (AORT)2025-12-31$39.88M+79.3%

Compare UFPT, BVS, NVCR, ATRC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗